Is "Prepectoral Edema" a Morphologic Sign for Malignant Breast Tumors?

Academic Radiology

Volumn 22, Issue 6, 2015, Pages 684-689

  Kaiser, Clemens G ^a   Herold, Michael ^b   Baltzer, Pascal A T ^c   Dietzel, Matthias ^d   Krammer, Julia ^a   Gajda, Mieczyslaw ^b   Camara, Oumar ^b   Schoenberg, Stefan O ^a   Kaiser, Werner A ^c   Wasser, Klaus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Breast cancer; Malignancy; MR mammography; Prepectoral edema

Indexed keywords

ADULT; ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST CARCINOMA; BREAST FIBROADENOMA; BREAST HAMARTOMA; BREAST LESION; BREAST PAPILLOMA; CANCER SIZE; CARCINOMA IN SITU; CYSTOSARCOMA PHYLLOIDES; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; EDEMA; FEMALE; FIBROCYSTIC BREAST DISEASE; HEMANGIOMA; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PREDICTIVE VALUE; PREPECTORAL EDEMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BREAST; BREAST NEOPLASMS; COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REPRODUCIBILITY;

BREAST; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; EDEMA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84929046578     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2015.01.009     Document Type: Article

References (33)

1. Burnside E.S., Sickles E.A., Bassett L.W., et al. The ACR BI-RADS experience: learning from history. J Am Coll Radiol 2009, 6(12):851-860.
2. Kaiser W.A. Magnetresonanztomographie der Mamma. Erfahrungen nach 253 Untersuchungen. Dtsch Med Wochenschr 1989, 114:1351-1357.
3. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285(21):1182-1186.
4. Bick U. Typical and unusual findings in MR mammography. RöFo Fortschritte Auf Dem Geb. Röntgenstrahlen Nukl 2000, 172(5):415-428.
5. Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007, 244(2):356-378.
6. Fischer D.R., Baltzer P., Malich A., et al. Is the "blooming sign" a promising additional tool to determine malignancy in MR mammography?. Eur Radiol 2004, 14(3):394-401.
7. Kuhl C.K., Klaschik S., Mielcarek P., et al. Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI?. J Magn Reson Imaging 1999, 9(2):187-196.
8. Fischer D.R., Wurdinger S., Boettcher J., et al. Further signs in the evaluation of magnetic resonance mammography: a retrospective study. Invest Radiol 2005, 40(7):430-435.
9. Baltzer P.A.T., Yang F., Dietzel M., et al. Sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-mammography considering 974 histologically verified lesions. Breast J 2010, 16(3):233-239.
10. Kaiser WA. Signs in MR-mammography. 1st ed. 2008. Corr. 2nd printing. Springer;2009.
11. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986, 315(26):1650-1659.
12. Horst H.A., Horny H.P. Characterization and frequency distribution of lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal carcinoma of the breast. Cancer 1987, 60(12):3001-3007.
13. van Ravenswaay Claasen H.H., Kluin P.M., Fleuren G.J. Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab Investig J Tech Methods Pathol 1992, 67(2):166-174.
14. Leek R.D., Talks K.L., Pezzella F., et al. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res 2002, 62(5):1326-1329.
15. Sica A., Saccani A., Mantovani A. Tumor-associated macrophages: a molecular perspective. Int Immunopharmacol 2002, 2(8):1045-1054.
16. Pathologie 4. Weibliches Genitale; Mamma; pathologie der schwangerschaft, der plazenta und des neugeborenen; infektionskrankheiten des fetus. . . 1997, Springer, Berlin.
17. Dvorak H.F., Dickersin G.R., Dvorak A.M., et al. Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction. J Natl Cancer Inst 1981, 67(2):335-345.
18. Hashizume H., Baluk P., Morikawa S., et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000, 156(4):1363-1380.
19. Pettersson A., Nagy J.A., Brown L.F., et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Investig J Tech Methods Pathol 2000, 80(1):99-115.
20. Dvorak H.F. Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. Am J Pathol 2003, 162(6):1747-1757.
21. Sunderkötter C., Steinbrink K., Goebeler M., et al. Macrophages and angiogenesis. J Leukoc Biol 1994, 55(3):410-422.
22. Sherif H., Mahfouz A.E., Oellinger H., et al. Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 1997, 205(1):209-213.
23. Brown L.F., Guidi A.J., Schnitt S.J., et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999, 5(5):1041-1056.
24. Uematsu T., Kasami M., Watanabe J. Is evaluation of the presence of prepectoral edema on T2-weighted with fat-suppression 3 T breast MRI a simple and readily available noninvasive technique for estimation of prognosis in patients with breast cancer?. Breast Cancer 2014, 21(6):684-692.
25. Uematsu T., Kasami M., Watanabe J. Can T2-weighted 3-T breast MRI predict clinically occult inflammatory breast cancer before pathological examination? A single-center experience. Breast Cancer 2014, 21(1):115-121.
26. Gilles R., Meunier M., Lucidarme O., et al. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J Comput Assist Tomogr 1996, 20(1):9-14.
27. Westerhof J.P., Fischer U., Moritz J.D., et al. MR imaging of mammographically detected clustered microcalcifications: is there any value?. Radiology 1998, 207(3):675-681.
28. Hayes D.F., Isaacs C., Stearns V. Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 2001, 6(4):375-392.
29. Fischer U., Zachariae O., Baum F., et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004, 14(10):1725-1731.
30. Carter C.L., Allen C., Henson D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989, 63(1):181-187.
31. Folkman J., Shing Y. Angiogenesis. J Biol Chem 1992, 267(16):10931-10934.
32. Macéa J.R., Fregnani J.H.T.G. Anatomy of the thoracic wall, axilla and breast. Int J Morphol 2006, 24(4):691-704.
33. Baltzer P.A., Dietzel M., Gajda, et al. A systematic comparison of two pulse sequences for edema assessment in MR-mammography. Eur J Radiol 2012, 81(7):1500-1503.